查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046655

醫療營養市場－全球產業規模、佔有率、趨勢、機會、預測：按給藥途徑、應用、最終用戶、地區和競爭格局分類，2021-2031年

Medical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療營養市場預計將從 2025 年的 639.1 億美元大幅成長至 2031 年的 1,003.5 億美元，複合年成長率為 7.81%。

該領域涵蓋多種治療產品，例如經腸營養和靜脈營養補充劑以及口服營養補充劑，所有這些產品均在專家指導下研發，旨在滿足不同疾病患者的特定營養需求。推動該市場成長的主要因素是慢性病盛行率的不斷上升以及全球老年人口的快速成長，而老年人口需要專業的臨床營養管理。例如，營養不良工作小組估計，到2025年，英國約有130萬65歲及以上的老年人將面臨營養不良，凸顯了老年族群營養干預的迫切性。這也進一步推動了對旨在改善患者預後和復原的專用產品的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 639.1億美元
市場規模：2031年 1003.5億美元
複合年成長率：2026-2031年 7.81%
成長最快的細分市場 口服和腸內
最大的市場 北美洲

然而，該市場面臨許多障礙，主要源自於嚴格的法規結構和複雜的報銷體系。製造商常常難以滿足各種法律要求並確保其產品獲得足夠的經濟補償，這可能會阻礙新治療方法的推廣。這些監管和經濟障礙會限制患者獲得所需產品，並延緩關鍵營養解決方案的上市，對整體市場擴張構成重大挑戰。

市場促進因素

慢性病和代謝性疾病的日益增多是全球醫用營養市場的主要驅動力，顯著提升了對疾病特異性營養療法的需求。隨著糖尿病和癌症等疾病的日益普遍，醫療專業人員越來越重視標靶營養療法，以控制症狀並改善治療效果。這一趨勢推動了專業產品的研發，例如用於血糖值控制的低升糖指數（GI）產品和用於預防癌症患者肌肉流失的高蛋白質補充劑。世界衛生組織（WHO）於2025年5月發布的《2025年世界衛生統計報告》強調了綜合營養管理的迫切性。報告指出，非傳染性疾病目前是全球70歲以下人口過早死亡的主要原因，因此，長期治療方案的需求仍然存在。

同時，醫院內臨床營養不良發生率的不斷上升正推動市場擴張，因為醫療機構越來越重視營養照護以減輕經濟負擔。由於住院患者的營養不良會導致復健延遲和住院時間延長，管理者正在實施嚴格的干涉方案。根據美國腸外經腸營養學會 (ASPEN) 於 2025 年 9 月舉辦的「2025 年營養不良意識週」的資料顯示，未經治療的營養不良可使醫院成本增加約 73%，並顯著增加再入院的可能性。因此，製造商們看到了對旨在促進臨床康復的腸內和腸外營養產品的強勁需求。達能於 2025 年 10 月發布的 2025 年第三季銷售新聞稿顯示，其成人醫學營養業務的銷售額實現了兩位數的成長，顯示人們越來越依賴治療性營養來緩解臨床併發症。

市場挑戰

全球醫用營養市場的成長受到嚴格法規環境和複雜報銷體系的顯著限制。製造商必須應對高度分散的法律標準，產品分類因地區而異，藥品和膳食補充劑之間的界限也往往模糊不清。這種監管上的不一致增加了合規成本，延長了新療法製劑的上市時間，從而減緩了產生收入，並降低了創新動力。

此外，不可預測的報銷政策直接阻礙了市場擴張，限制了患者獲得必需產品的途徑。儘管臨床療效已得到證實，但許多營養療法缺乏穩定的醫療覆蓋，導致患者和醫療服務提供者都難以負擔。這種經濟差距阻礙了市場充分利用營養不良管理的迫切需求。根據國際醫療營養產業協會（MNI）的數據，預計到2025年，歐洲與疾病相關的營養不良造成的經濟負擔將達到每年1700億歐元。這一巨額數字凸顯了行政和財務障礙如何有效地阻礙了基本營養干預措施的廣泛應用，導致巨大的潛在市場未能開發，並對整個行業的收入產生了負面影響。

市場趨勢

GLP-1受體促效劑在體重管理領域的快速普及，正在醫學營養領域開闢一個新的市場區隔。該領域尤其致力於在快速減重期間維持瘦肌肉量並確保充足的微量營養素攝取。由於這些藥物會顯著抑制食慾，患者往往難以滿足每日營養需求，因此，針對肌肉減少症性肥胖的高蛋白、低劑量口服營養補充劑（ONS）的需求日益成長。製造商正積極改進現有的糖尿病產品，以滿足血糖控制和肌肉維持的雙重需求。根據雅培公司2025年1月發布的題為「強勁的第四季動能將推動2025年實現強勁成長」的新聞稿，該公司營養部門的銷售額成長了7.2%。這主要得益於市場對Glucerna和Ensure產品的強勁需求，這些產品旨在支持接受GLP-1治療的患者。

同時，受消費者對無過敏原和環保成分的需求驅動，市場正顯著轉向植物來源經腸營養和補充劑。雖然該行業傳統上依賴乳蛋白質配方，但目前擴大採用水解豌豆蛋白和大豆蛋白來改善胃腸道耐受性，並迎合食品飲料行業對「潔淨標示」的普遍偏好。為了因應這一趨勢，各大公司正在調整其產品系列，包括收購專注植物來源的新創公司，以拓展不斷成長的客戶群。根據《每日記者報》2025年10月的報道，達能旗下專門食品營養品部門在2025年前三個季度的銷售額佔集團總銷售額的33.5%，這主要得益於近期對植物來源產品的投資。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫用營養品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 給藥途徑（口服、腸內、腸外）
    • 依應用領域（營養不良、代謝性疾病、消化系統疾病、癌症、神經系統疾病等）
    • 依最終使用者（兒童、成人）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫用營養品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫用營養品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫療營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲醫療營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲醫療營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫療營養市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Nutrition Ltd
  • Nestle Health Science SA
  • Baxter Healthcare Corp
  • B Braun SE
  • Danone SA
  • Perrigo Co PLC
  • Fresenius Kabi AG
  • AYMES Nutrition
  • Reckitt Benckiser Group PLC
  • Ajinomoto Cambrooke Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20595

The global medical nutrition market is projected to expand significantly, rising from USD 63.91 billion in 2025 to USD 100.35 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.81%. This sector encompasses therapeutic products, such as enteral and parenteral formulations, alongside oral nutritional supplements, all developed to address the specific dietary needs of patients with various medical conditions under expert guidance. Key factors driving this market's growth are the increasing incidence of chronic diseases and a rapidly expanding elderly global population requiring specialized clinical dietary management. For instance, an estimated 1.3 million individuals over 65 in the UK were malnourished in 2025, according to the Malnutrition Task Force, highlighting the critical need for nutritional interventions in the geriatric population, which in turn fuels the demand for specialized products aimed at enhancing patient outcomes and recovery.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 63.91 Billion
Market Size 2031USD 100.35 Billion
CAGR 2026-20317.81%
Fastest Growing SegmentOral and Enteral
Largest MarketNorth America

Nevertheless, the market faces considerable hurdles, primarily due to rigorous regulatory frameworks and intricate reimbursement systems. Producers frequently struggle with navigating varied legal requirements and obtaining adequate financial coverage for their offerings, which can impede the launch of new treatments. These regulatory and economic impediments have the potential to restrict patient accessibility and postpone the market introduction of vital nutritional solutions, thereby presenting a notable challenge to the overall expansion of the market.

Market Driver

The increasing occurrence of chronic and metabolic disorders is a major impetus for the global medical nutrition market, driving a significant demand for dietary interventions tailored to specific diseases. With conditions like diabetes and cancer becoming more prevalent, healthcare professionals are increasingly turning to targeted nutritional therapies to manage symptoms and improve treatment effectiveness. This trend spurs the creation of specialized products, such as low-glycemic index options for blood sugar control and high-protein supplements for cancer patients to prevent muscle wasting. The urgency for integrated nutritional management is highlighted by the World Health Organization's 'World Health Statistics 2025' report from May 2025, which states that noncommunicable diseases are now responsible for most premature deaths globally among individuals under 70, thereby ensuring a continuous need for long-term therapeutic solutions.

Concurrently, the growing incidence of clinical malnutrition within hospitals is boosting market expansion, as healthcare institutions focus on nutritional care to lessen financial strains. Malnutrition among hospitalized patients is associated with slower recovery and longer hospital stays, leading administrators to implement stringent intervention protocols. According to resources from the American Society for Parenteral and Enteral Nutrition's 'Malnutrition Awareness Week 2025' in September 2025, untreated malnutrition can raise hospital costs by about 73% and considerably increase the chance of readmission. Consequently, manufacturers are observing strong demand for enteral and parenteral products designed for clinical recovery, as evidenced by Danone's 'Third Quarter 2025 Sales' press release in October 2025, which reported double-digit sales growth in its adult medical nutrition division, indicating a heightened reliance on therapeutic nutrition to alleviate clinical complications.

Market Challenge

The global medical nutrition market's growth is significantly hindered by stringent regulatory environments and complicated reimbursement systems. Producers are required to navigate highly fragmented legal standards, where product categorization differs substantially across regions, frequently blurring the distinction between pharmaceutical drugs and food supplements. This lack of regulatory uniformity elevates compliance expenditures and extends the duration needed to launch new therapeutic formulations, consequently delaying revenue generation and diminishing the motivation for innovation.

Moreover, unpredictable reimbursement policies directly impede market expansion by restricting patients' access to crucial products. Despite clinical validation, numerous nutritional therapies often do not receive consistent insurance coverage, rendering them financially inaccessible for both patients and healthcare providers. This economic gap prevents the market from fully leveraging the pressing need for malnutrition management. Data from the Medical Nutrition International Industry (MNI) indicates that in 2025, the economic burden of disease-related malnutrition in Europe was an estimated €170 billion annually. This substantial sum underscores how administrative and financial obstacles effectively prevent the broad adoption of essential nutritional interventions, leaving a vast potential market undeveloped and negatively impacting overall industry revenue.

Market Trends

The swift uptake of GLP-1 receptor agonists for managing weight is establishing a new segment within the medical nutrition sector, specifically targeting the preservation of lean muscle mass and adequate micronutrient intake during accelerated weight reduction. Since these medications notably curb appetite, patients frequently find it challenging to fulfill their daily nutritional needs, thereby fueling the demand for high-protein, low-volume oral nutritional supplements (ONS) formulated to combat sarcopenic obesity. Manufacturers are proactively adapting existing diabetes-specific products to address both glycemic control and muscle upkeep requirements. Abbott's 'Q4 Momentum Positions Abbott for Strong Growth in 2025' press release from January 2025 indicated a 7.2% sales increase in its Nutrition segment, largely propelled by strong demand for Glucerna and Ensure products supporting patients on GLP-1 therapies.

Simultaneously, the market is undergoing a significant transition towards plant-based enteral feeding formulas and supplements, spurred by consumer demand for allergen-free and environmentally friendly components. While the industry has traditionally relied on milk-protein formulations, there is a growing trend to integrate hydrolyzed pea and soy proteins to enhance gastrointestinal tolerance and align with the clean-label preferences common in the wider food and beverage industry. This development is prompting a reconfiguration of product portfolios, as leading companies acquire niche plant-based startups to attract this expanding demographic. As reported by Dairy Reporter in October 2025, Danone's Specialized Nutrition division, boosted by recent plant-based investments, contributed 33.5% to the company's total group sales during the first nine months of 2025.

Key Market Players

  • Abbott Nutrition Ltd
  • Nestle Health Science SA
  • Baxter Healthcare Corp
  • B Braun SE
  • Danone SA
  • Perrigo Co PLC
  • Fresenius Kabi AG
  • AYMES Nutrition
  • Reckitt Benckiser Group PLC
  • Ajinomoto Cambrooke Inc.

Report Scope

In this report, the Global Medical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Nutrition Market, By Route of Administration

  • Oral and Enteral
  • Parenteral

Medical Nutrition Market, By Application

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Diseases
  • Cancer
  • Neurological Diseases
  • Others

Medical Nutrition Market, By End User

  • Pediatric
  • Adult

Medical Nutrition Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Nutrition Market.

Available Customizations:

Global Medical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 5.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 5.2.3. By End User (Pediatric, Adult)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Medical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Route of Administration
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Route of Administration
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Medical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Route of Administration
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Medical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Route of Administration
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Medical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Route of Administration
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Route of Administration
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Medical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Route of Administration
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Medical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Route of Administration
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Medical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Route of Administration
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Medical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Route of Administration
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Medical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Route of Administration
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Route of Administration
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Medical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Route of Administration
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Medical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Route of Administration
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Medical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Route of Administration
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Medical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Route of Administration
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Medical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Route of Administration
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Route of Administration
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Medical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Route of Administration
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Medical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Route of Administration
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Medical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Route of Administration
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Route of Administration
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Medical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Route of Administration
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Medical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Route of Administration
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Nutrition Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Nestle Health Science SA
  • 15.3. Baxter Healthcare Corp
  • 15.4. B Braun SE
  • 15.5. Danone SA
  • 15.6. Perrigo Co PLC
  • 15.7. Fresenius Kabi AG
  • 15.8. AYMES Nutrition
  • 15.9. Reckitt Benckiser Group PLC
  • 15.10. Ajinomoto Cambrooke Inc.

16. Strategic Recommendations

17. About Us & Disclaimer